MIF
NVO

Mediolanum International Funds’s Novo Nordisk NVO Stock Holding History

Mediolanum International Funds’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-151,856
Closed -$10.4M – 427
2025
Q2 		$10.4M Buy
+151,856
New +$10.3M 0.12% 175
2024
Q4 		– Sell
-828,479
Closed -$98.8M – 475
2024
Q3 		$98.8M Buy
+828,479
New +$110M 1.37% 11

Other funds holding NVO

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Mediolanum International Funds's NVO Position: Q3 2025 in Review

Mediolanum International Funds sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 151,856 shares — an estimated $10.4M sold.

Mediolanum International Funds first reported a position in NVO in Q3 2024 and held it in 2 quarters. The position peaked at $98.8M in Q3 2024. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

  • Mediolanum International Funds reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
  • Mediolanum International Funds sold 151,856 Novo Nordisk shares in Q3 2025, an estimated $10.4M.
  • Mediolanum International Funds first reported a position in Novo Nordisk in Q3 2024 and held it in 2 quarters.
  • Mediolanum International Funds's Novo Nordisk position peaked at $98.8M in Q3 2024.
  • 1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Mediolanum International Funds's 13F filing for Q3 2025, filed 4 Nov 2025.